Larvol Delta - Imara-Reports-Phase-2a-Clinical-Trial-Results-of-IMR687-in-Adult-Patients-with-Sickle-Cell-Disease

IMR-687 - Imara, Inc

http://www.globenewswire.com/news-release/2021/01/06/2154071/0/en/Imara-Reports-Phase-2a-Clinical-Trial-Results-of-IMR-687-in-Adult-Patients-with-Sickle-Cell-Disease.html

Jan 6, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next